CAJ | 학술논문

目的通过观察某院收治的妊娠期糖尿病分娩孕妇临床治疗资料,探讨分析乙肝病毒(HBV)携带载量对妊娠期糖尿病(GDM)的发生率及对妊娠结局的影响.方法对13 565例住院分娩孕妇分为乙型肝炎病毒携带病毒载量阳性组(A组)、病毒载量阴性组(B组)及非乙型肝炎病毒携带组(C组)三组,均进行肝功能、HBV血清学、血糖等方面的检测,并记录相关妊娠结局情况,对比分析三组GDM发生率、产妇糖尿病的预后情况以及对胎儿的影响情况.结果 A组中GDM的发生率为3.80％,B组中GDM的发生率为4.03％,C组中GDM的发生率为2.36％,三组13 565例孕妇中不同乙肝病毒载量之间GDM的发生率、产妇糖尿病的预后以及对胎儿的影响情况等差异无统计学意义(P＞0.05).结论乙肝病毒(HBV)携带载量的妊娠期糖尿病(GDM)的发生率对比差异无统计学意义,且病毒载量的水平不改变糖尿病的预后以及胎儿差异情况,妊娠结局未受影响,但是乙肝病毒携带者GDM的发生率对比非乙肝病毒携带者孕妇明显高.
목적 통과관찰모원수치적임신기당뇨병분면잉부림상치료자료,탐토분석을간병독(HBV)휴대재량대임신기당뇨병(GDM)적발생솔급대임신결국적영향.방법 대13 565례주원분면잉부분위을형간염병독휴대병독재량양성조(A조)、병독재량음성조(B조)급비을형간염병독휴대조(C조)삼조,균진행간공능、HBV혈청학、혈당등방면적검측,병기록상관임신결국정황,대비분석삼조GDM발생솔、산부당뇨병적예후정황이급대태인적영향정황.결과 A조중GDM적발생솔위3.80％,B조중GDM적발생솔위4.03％,C조중GDM적발생솔위2.36％,삼조13 565례잉부중불동을간병독재량지간GDM적발생솔、산부당뇨병적예후이급대태인적영향정황등차이무통계학의의(P＞0.05).결론 을간병독(HBV)휴대재량적임신기당뇨병(GDM)적발생솔대비차이무통계학의의,차병독재량적수평불개변당뇨병적예후이급태인차이정황,임신결국미수영향,단시을간병독휴대자GDM적발생솔대비비을간병독휴대자잉부명현고.
Objective Through observing the clinical data of patients with gestational diabetes mellitus (GDM),to,analyze the influence of hepatitis B virus (HBV) viral load on pregnancy outcome of GDM patients.Methods 13565 cases of pregnant women were divided into HBV carry virus positive group(group A),virus negative group(group B) and the non HBV carry group(C group).The liver function,HBV serological test,blood sugar,etc were detected in all three groups,and related pregnancy outcome was recorded.The incidence rate of GDM,prognosis of maternal diabetes and its influence to the fetus were compared.Results The incidence rate of GDM in A,B,C group was 3.80％,4.03％,2.36％,respectively.The incidence rate of GDM in different HBV viral load pregnant women,prognosis of maternal diabetes and the influence to the fetus between groups had,no statistically significant differences (P ＞0.05).Conclusion The incidence rate of GDM in different HBV carrying capacity patients had no significant difference,and viral load level did not change the prognosis of diabetes and fetal variance,the pregnancy outcome was not affected,but the incidence rate of GDM in HBV carriers was higher than non HBV carriers.